Oramed Pharmaceuticals
ORMP
ORMP
21 hedge funds and large institutions have $1.32M invested in Oramed Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Holders
21
Holding in Top 10
–
Calls
$1.08M
Puts
$51K
Top Buyers
| 1 | +$53.7K | |
| 2 | +$28.4K | |
| 3 | +$9.47K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.88K |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
+$4.5K |
Top Sellers
| 1 | -$164K | |
| 2 | -$140K | |
| 3 | -$60.1K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$13K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$10.9K |